Incidence, predictors, and outcomes of gastrointestinal bleeding in patients on dual antiplatelet therapy with aspirin and clopidogrel Academic Article uri icon

Overview

MeSH Major

  • Aspirin
  • Gastrointestinal Hemorrhage
  • Platelet Aggregation Inhibitors
  • Ticlopidine

abstract

  • The rate of GI bleeding in patients on dual antiplatelet therapy is low. Earlier history of GI bleeding is the most significant multivariate predictor of future GI bleeding whereas statins seemed to be protective. Patients with GI bleeding have increased short-term and long-term mortality; thereby a history of earlier GI bleeding needs to be assessed carefully before starting dual antiplatelet therapy. This may play a vital role in the selection of therapeutic strategies in these patients.

publication date

  • May 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/MCG.0b013e3181faec3c

PubMed ID

  • 20975574

Additional Document Info

start page

  • 410

end page

  • 4

volume

  • 45

number

  • 5